Loading…
A population‐based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy
Study Type – Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? The National Comprehensive Cancer Network guidelines recommend pelvic lymph node dissection in patients with a nomogram‐predicted lymph node invasion risk of 2% or more. We set out to e...
Saved in:
Published in: | BJU international 2012-04, Vol.109 (8), p.1177-1182 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4278-510f09f2c6d06bc3ab5c65b9448ed216327d456e34a7ad9afecd52d54f04ac503 |
---|---|
cites | cdi_FETCH-LOGICAL-c4278-510f09f2c6d06bc3ab5c65b9448ed216327d456e34a7ad9afecd52d54f04ac503 |
container_end_page | 1182 |
container_issue | 8 |
container_start_page | 1177 |
container_title | BJU international |
container_volume | 109 |
creator | Abdollah, Firas Schmitges, Jan Sun, Maxine Shariat, Shahrokh F. Briganti, Alberto Abdo, Al'a Tian, Zhe Perrotte, Paul Montorsi, Francesco Karakiewicz, Pierre I. |
description | Study Type – Therapy (cohort)
Level of Evidence 2b
What's known on the subject? and What does the study add?
The National Comprehensive Cancer Network guidelines recommend pelvic lymph node dissection in patients with a nomogram‐predicted lymph node invasion risk of 2% or more. We set out to examine the validity of this recommendation.
OBJECTIVES
•
To examine the ability of the threshold recommended by the National Comprehensive Cancer Network (NCCN) in correctly predicting histologically‐confirmed lymph node invasion (LNI).
•
The 2010 NCCN practice guidelines for prostate cancer recommend a pelvic lymph node dissection (PLND) at radical prostatectomy in all individuals with a nomogram predicted LNI risk of ≥2%.
PATIENTS AND METHODS
•
We assessed 20 877 patients who were treated with radical prostatectomy and PLND between 2004 and 2006, within the Surveillance, Epidemiology and End Results database.
•
The 2% nomogram threshold, as well as other threshold values (range 1–10%) were tested.
•
Finally, we externally validated the NCCN guideline nomogram.
RESULTS
•
Overall, 2.5% of patients had LNI.
•
The use of the 2% threshold would allow the avoidance of 23% of PLNDs, at the cost of missing 1.7% of patients with LNI. Conversely, the use of a 3% threshold would allow the avoidance of 58% of PLNDs, at the cost of missing 15% of patients with LNI vs 72% and 26%, respectively, for the 4% threshold.
•
Overall, the accuracy of the NCCN guideline nomogram quantified according to the receiver‐operator characteristics‐derived area under the curve was 82%.
CONCLUSIONS
•
In a population‐based sample, the NCCN guideline nomogram is highly accurate.
•
However, the 2% threshold will permit the avoidance of only 23% of PLNDs, instead of the 48% intended by the NCCN guidelines.
•
The use of a 3% threshold may allow a lower rate of PLND overtreatment, although it will miss more patients with LNI. |
doi_str_mv | 10.1111/j.1464-410X.2011.10518.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_963490692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2975487891</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4278-510f09f2c6d06bc3ab5c65b9448ed216327d456e34a7ad9afecd52d54f04ac503</originalsourceid><addsrcrecordid>eNqNkUuO1DAQhiMEYh5wBWQJIVYd_O5kgzS0eGo0bBiJneW2K7QbJw52MjO9myNwCS7GSXDSPYPECm9ccn1_lav-okAElySfV9uScMkXnOCvJcWElAQLUpU3D4rj-8TDuxjX8qg4SWmLcX6Q4nFxRElV4aw5Ln6doT70o9eDC93v259rncAinRKk1EI3oNCgYQPoYga0R6vQ9hE20CV3BWilOwMRXcBwHeJ31EdtBmcAfRudBe86QK6zzszihJoQUQ_-yhnkd22_QV2wgKzL3cxEID2gqCfe51IhDXrIidDunhSPGu0TPD3cp8Xlu7dfVh8W55_ff1ydnS8Mp8tqIQhucN1QIy2Wa8P0Whgp1jXnFVhKJKNLy4UExvVS21o3YKygVvAGc20EZqfFy33d3P3HCGlQrUsGvNcdhDGpWjJeY1nTTD7_h9yGMeYFJUWYYExSOlPVnjJ5mhShUX10rY47RbCanFRbNZmkJsPU5KSanVQ3Wfrs0GBct2DvhXfWZeDFAdApL6yJ2QqX_nJiWTFBp5le77lr52H33x9Qbz5dziH7A9ItvrE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1353362292</pqid></control><display><type>article</type><title>A population‐based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Abdollah, Firas ; Schmitges, Jan ; Sun, Maxine ; Shariat, Shahrokh F. ; Briganti, Alberto ; Abdo, Al'a ; Tian, Zhe ; Perrotte, Paul ; Montorsi, Francesco ; Karakiewicz, Pierre I.</creator><creatorcontrib>Abdollah, Firas ; Schmitges, Jan ; Sun, Maxine ; Shariat, Shahrokh F. ; Briganti, Alberto ; Abdo, Al'a ; Tian, Zhe ; Perrotte, Paul ; Montorsi, Francesco ; Karakiewicz, Pierre I.</creatorcontrib><description>Study Type – Therapy (cohort)
Level of Evidence 2b
What's known on the subject? and What does the study add?
The National Comprehensive Cancer Network guidelines recommend pelvic lymph node dissection in patients with a nomogram‐predicted lymph node invasion risk of 2% or more. We set out to examine the validity of this recommendation.
OBJECTIVES
•
To examine the ability of the threshold recommended by the National Comprehensive Cancer Network (NCCN) in correctly predicting histologically‐confirmed lymph node invasion (LNI).
•
The 2010 NCCN practice guidelines for prostate cancer recommend a pelvic lymph node dissection (PLND) at radical prostatectomy in all individuals with a nomogram predicted LNI risk of ≥2%.
PATIENTS AND METHODS
•
We assessed 20 877 patients who were treated with radical prostatectomy and PLND between 2004 and 2006, within the Surveillance, Epidemiology and End Results database.
•
The 2% nomogram threshold, as well as other threshold values (range 1–10%) were tested.
•
Finally, we externally validated the NCCN guideline nomogram.
RESULTS
•
Overall, 2.5% of patients had LNI.
•
The use of the 2% threshold would allow the avoidance of 23% of PLNDs, at the cost of missing 1.7% of patients with LNI. Conversely, the use of a 3% threshold would allow the avoidance of 58% of PLNDs, at the cost of missing 15% of patients with LNI vs 72% and 26%, respectively, for the 4% threshold.
•
Overall, the accuracy of the NCCN guideline nomogram quantified according to the receiver‐operator characteristics‐derived area under the curve was 82%.
CONCLUSIONS
•
In a population‐based sample, the NCCN guideline nomogram is highly accurate.
•
However, the 2% threshold will permit the avoidance of only 23% of PLNDs, instead of the 48% intended by the NCCN guidelines.
•
The use of a 3% threshold may allow a lower rate of PLND overtreatment, although it will miss more patients with LNI.</description><identifier>ISSN: 1464-4096</identifier><identifier>EISSN: 1464-410X</identifier><identifier>DOI: 10.1111/j.1464-410X.2011.10518.x</identifier><identifier>PMID: 21880105</identifier><identifier>CODEN: BJINFO</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adenocarcinoma - epidemiology ; Adenocarcinoma - secondary ; Adenocarcinoma - surgery ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Biopsy ; Dissection ; Follow-Up Studies ; Guideline Adherence ; Hematologic and hematopoietic diseases ; Humans ; Incidence ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymph Node Excision - methods ; lymph node excision/statistics and numerical data ; Lymph Nodes - pathology ; Lymph Nodes - surgery ; Lymphatic Metastasis ; lymphatic metastasis/diagnosis ; Lymphatic system ; Male ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Pelvis ; Prostatectomy - methods ; prostatic neoplasm/pathology ; Prostatic Neoplasms - epidemiology ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - surgery ; Retrospective Studies ; Risk Assessment - methods ; SEER Program ; Survival Rate - trends ; Tumors of the urinary system ; Urinary tract. Prostate gland</subject><ispartof>BJU international, 2012-04, Vol.109 (8), p.1177-1182</ispartof><rights>2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL</rights><rights>2015 INIST-CNRS</rights><rights>2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4278-510f09f2c6d06bc3ab5c65b9448ed216327d456e34a7ad9afecd52d54f04ac503</citedby><cites>FETCH-LOGICAL-c4278-510f09f2c6d06bc3ab5c65b9448ed216327d456e34a7ad9afecd52d54f04ac503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25783520$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21880105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdollah, Firas</creatorcontrib><creatorcontrib>Schmitges, Jan</creatorcontrib><creatorcontrib>Sun, Maxine</creatorcontrib><creatorcontrib>Shariat, Shahrokh F.</creatorcontrib><creatorcontrib>Briganti, Alberto</creatorcontrib><creatorcontrib>Abdo, Al'a</creatorcontrib><creatorcontrib>Tian, Zhe</creatorcontrib><creatorcontrib>Perrotte, Paul</creatorcontrib><creatorcontrib>Montorsi, Francesco</creatorcontrib><creatorcontrib>Karakiewicz, Pierre I.</creatorcontrib><title>A population‐based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy</title><title>BJU international</title><addtitle>BJU Int</addtitle><description>Study Type – Therapy (cohort)
Level of Evidence 2b
What's known on the subject? and What does the study add?
The National Comprehensive Cancer Network guidelines recommend pelvic lymph node dissection in patients with a nomogram‐predicted lymph node invasion risk of 2% or more. We set out to examine the validity of this recommendation.
OBJECTIVES
•
To examine the ability of the threshold recommended by the National Comprehensive Cancer Network (NCCN) in correctly predicting histologically‐confirmed lymph node invasion (LNI).
•
The 2010 NCCN practice guidelines for prostate cancer recommend a pelvic lymph node dissection (PLND) at radical prostatectomy in all individuals with a nomogram predicted LNI risk of ≥2%.
PATIENTS AND METHODS
•
We assessed 20 877 patients who were treated with radical prostatectomy and PLND between 2004 and 2006, within the Surveillance, Epidemiology and End Results database.
•
The 2% nomogram threshold, as well as other threshold values (range 1–10%) were tested.
•
Finally, we externally validated the NCCN guideline nomogram.
RESULTS
•
Overall, 2.5% of patients had LNI.
•
The use of the 2% threshold would allow the avoidance of 23% of PLNDs, at the cost of missing 1.7% of patients with LNI. Conversely, the use of a 3% threshold would allow the avoidance of 58% of PLNDs, at the cost of missing 15% of patients with LNI vs 72% and 26%, respectively, for the 4% threshold.
•
Overall, the accuracy of the NCCN guideline nomogram quantified according to the receiver‐operator characteristics‐derived area under the curve was 82%.
CONCLUSIONS
•
In a population‐based sample, the NCCN guideline nomogram is highly accurate.
•
However, the 2% threshold will permit the avoidance of only 23% of PLNDs, instead of the 48% intended by the NCCN guidelines.
•
The use of a 3% threshold may allow a lower rate of PLND overtreatment, although it will miss more patients with LNI.</description><subject>Adenocarcinoma - epidemiology</subject><subject>Adenocarcinoma - secondary</subject><subject>Adenocarcinoma - surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Dissection</subject><subject>Follow-Up Studies</subject><subject>Guideline Adherence</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Incidence</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymph Node Excision - methods</subject><subject>lymph node excision/statistics and numerical data</subject><subject>Lymph Nodes - pathology</subject><subject>Lymph Nodes - surgery</subject><subject>Lymphatic Metastasis</subject><subject>lymphatic metastasis/diagnosis</subject><subject>Lymphatic system</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Pelvis</subject><subject>Prostatectomy - methods</subject><subject>prostatic neoplasm/pathology</subject><subject>Prostatic Neoplasms - epidemiology</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - surgery</subject><subject>Retrospective Studies</subject><subject>Risk Assessment - methods</subject><subject>SEER Program</subject><subject>Survival Rate - trends</subject><subject>Tumors of the urinary system</subject><subject>Urinary tract. Prostate gland</subject><issn>1464-4096</issn><issn>1464-410X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqNkUuO1DAQhiMEYh5wBWQJIVYd_O5kgzS0eGo0bBiJneW2K7QbJw52MjO9myNwCS7GSXDSPYPECm9ccn1_lav-okAElySfV9uScMkXnOCvJcWElAQLUpU3D4rj-8TDuxjX8qg4SWmLcX6Q4nFxRElV4aw5Ln6doT70o9eDC93v259rncAinRKk1EI3oNCgYQPoYga0R6vQ9hE20CV3BWilOwMRXcBwHeJ31EdtBmcAfRudBe86QK6zzszihJoQUQ_-yhnkd22_QV2wgKzL3cxEID2gqCfe51IhDXrIidDunhSPGu0TPD3cp8Xlu7dfVh8W55_ff1ydnS8Mp8tqIQhucN1QIy2Wa8P0Whgp1jXnFVhKJKNLy4UExvVS21o3YKygVvAGc20EZqfFy33d3P3HCGlQrUsGvNcdhDGpWjJeY1nTTD7_h9yGMeYFJUWYYExSOlPVnjJ5mhShUX10rY47RbCanFRbNZmkJsPU5KSanVQ3Wfrs0GBct2DvhXfWZeDFAdApL6yJ2QqX_nJiWTFBp5le77lr52H33x9Qbz5dziH7A9ItvrE</recordid><startdate>201204</startdate><enddate>201204</enddate><creator>Abdollah, Firas</creator><creator>Schmitges, Jan</creator><creator>Sun, Maxine</creator><creator>Shariat, Shahrokh F.</creator><creator>Briganti, Alberto</creator><creator>Abdo, Al'a</creator><creator>Tian, Zhe</creator><creator>Perrotte, Paul</creator><creator>Montorsi, Francesco</creator><creator>Karakiewicz, Pierre I.</creator><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope></search><sort><creationdate>201204</creationdate><title>A population‐based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy</title><author>Abdollah, Firas ; Schmitges, Jan ; Sun, Maxine ; Shariat, Shahrokh F. ; Briganti, Alberto ; Abdo, Al'a ; Tian, Zhe ; Perrotte, Paul ; Montorsi, Francesco ; Karakiewicz, Pierre I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4278-510f09f2c6d06bc3ab5c65b9448ed216327d456e34a7ad9afecd52d54f04ac503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adenocarcinoma - epidemiology</topic><topic>Adenocarcinoma - secondary</topic><topic>Adenocarcinoma - surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Dissection</topic><topic>Follow-Up Studies</topic><topic>Guideline Adherence</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Incidence</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymph Node Excision - methods</topic><topic>lymph node excision/statistics and numerical data</topic><topic>Lymph Nodes - pathology</topic><topic>Lymph Nodes - surgery</topic><topic>Lymphatic Metastasis</topic><topic>lymphatic metastasis/diagnosis</topic><topic>Lymphatic system</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Pelvis</topic><topic>Prostatectomy - methods</topic><topic>prostatic neoplasm/pathology</topic><topic>Prostatic Neoplasms - epidemiology</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - surgery</topic><topic>Retrospective Studies</topic><topic>Risk Assessment - methods</topic><topic>SEER Program</topic><topic>Survival Rate - trends</topic><topic>Tumors of the urinary system</topic><topic>Urinary tract. Prostate gland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdollah, Firas</creatorcontrib><creatorcontrib>Schmitges, Jan</creatorcontrib><creatorcontrib>Sun, Maxine</creatorcontrib><creatorcontrib>Shariat, Shahrokh F.</creatorcontrib><creatorcontrib>Briganti, Alberto</creatorcontrib><creatorcontrib>Abdo, Al'a</creatorcontrib><creatorcontrib>Tian, Zhe</creatorcontrib><creatorcontrib>Perrotte, Paul</creatorcontrib><creatorcontrib>Montorsi, Francesco</creatorcontrib><creatorcontrib>Karakiewicz, Pierre I.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>BJU international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdollah, Firas</au><au>Schmitges, Jan</au><au>Sun, Maxine</au><au>Shariat, Shahrokh F.</au><au>Briganti, Alberto</au><au>Abdo, Al'a</au><au>Tian, Zhe</au><au>Perrotte, Paul</au><au>Montorsi, Francesco</au><au>Karakiewicz, Pierre I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A population‐based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy</atitle><jtitle>BJU international</jtitle><addtitle>BJU Int</addtitle><date>2012-04</date><risdate>2012</risdate><volume>109</volume><issue>8</issue><spage>1177</spage><epage>1182</epage><pages>1177-1182</pages><issn>1464-4096</issn><eissn>1464-410X</eissn><coden>BJINFO</coden><abstract>Study Type – Therapy (cohort)
Level of Evidence 2b
What's known on the subject? and What does the study add?
The National Comprehensive Cancer Network guidelines recommend pelvic lymph node dissection in patients with a nomogram‐predicted lymph node invasion risk of 2% or more. We set out to examine the validity of this recommendation.
OBJECTIVES
•
To examine the ability of the threshold recommended by the National Comprehensive Cancer Network (NCCN) in correctly predicting histologically‐confirmed lymph node invasion (LNI).
•
The 2010 NCCN practice guidelines for prostate cancer recommend a pelvic lymph node dissection (PLND) at radical prostatectomy in all individuals with a nomogram predicted LNI risk of ≥2%.
PATIENTS AND METHODS
•
We assessed 20 877 patients who were treated with radical prostatectomy and PLND between 2004 and 2006, within the Surveillance, Epidemiology and End Results database.
•
The 2% nomogram threshold, as well as other threshold values (range 1–10%) were tested.
•
Finally, we externally validated the NCCN guideline nomogram.
RESULTS
•
Overall, 2.5% of patients had LNI.
•
The use of the 2% threshold would allow the avoidance of 23% of PLNDs, at the cost of missing 1.7% of patients with LNI. Conversely, the use of a 3% threshold would allow the avoidance of 58% of PLNDs, at the cost of missing 15% of patients with LNI vs 72% and 26%, respectively, for the 4% threshold.
•
Overall, the accuracy of the NCCN guideline nomogram quantified according to the receiver‐operator characteristics‐derived area under the curve was 82%.
CONCLUSIONS
•
In a population‐based sample, the NCCN guideline nomogram is highly accurate.
•
However, the 2% threshold will permit the avoidance of only 23% of PLNDs, instead of the 48% intended by the NCCN guidelines.
•
The use of a 3% threshold may allow a lower rate of PLND overtreatment, although it will miss more patients with LNI.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21880105</pmid><doi>10.1111/j.1464-410X.2011.10518.x</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1464-4096 |
ispartof | BJU international, 2012-04, Vol.109 (8), p.1177-1182 |
issn | 1464-4096 1464-410X |
language | eng |
recordid | cdi_proquest_miscellaneous_963490692 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Adenocarcinoma - epidemiology Adenocarcinoma - secondary Adenocarcinoma - surgery Adult Aged Aged, 80 and over Biological and medical sciences Biopsy Dissection Follow-Up Studies Guideline Adherence Hematologic and hematopoietic diseases Humans Incidence Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymph Node Excision - methods lymph node excision/statistics and numerical data Lymph Nodes - pathology Lymph Nodes - surgery Lymphatic Metastasis lymphatic metastasis/diagnosis Lymphatic system Male Medical sciences Middle Aged Nephrology. Urinary tract diseases Pelvis Prostatectomy - methods prostatic neoplasm/pathology Prostatic Neoplasms - epidemiology Prostatic Neoplasms - pathology Prostatic Neoplasms - surgery Retrospective Studies Risk Assessment - methods SEER Program Survival Rate - trends Tumors of the urinary system Urinary tract. Prostate gland |
title | A population‐based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T06%3A11%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20population%E2%80%90based%20assessment%20of%20the%20National%20Comprehensive%20Cancer%20Network%20practice%20guideline%20indications%20for%20pelvic%20lymph%20node%20dissection%20at%20radical%20prostatectomy&rft.jtitle=BJU%20international&rft.au=Abdollah,%20Firas&rft.date=2012-04&rft.volume=109&rft.issue=8&rft.spage=1177&rft.epage=1182&rft.pages=1177-1182&rft.issn=1464-4096&rft.eissn=1464-410X&rft.coden=BJINFO&rft_id=info:doi/10.1111/j.1464-410X.2011.10518.x&rft_dat=%3Cproquest_cross%3E2975487891%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4278-510f09f2c6d06bc3ab5c65b9448ed216327d456e34a7ad9afecd52d54f04ac503%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1353362292&rft_id=info:pmid/21880105&rfr_iscdi=true |